ARS

AUTO-GENERATED PAPER DOCUMENT

Company: Protalix BioTherapeutics, Inc.
Filed: September 23, 2011
Period of Report: December 31, 2010
Accession Number: 9999999997-11-015874

View Document ↗ View on SEC.gov ↗